Company: PRGO
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0001585364-25-000056
Chunk: 22

Company: PERRIGO Co plc
Filing Date: 2025-05-07
Form: 10-Q
Item: Item 1
Chunk 22
---
 If we consummate certain qualifying acquisitions during the term of the loan, the maximum first lien secured net leverage ratio covenant would increase to 3.25 to 1.00 for such quarter and the three following fiscal quarters thereafter. During the three months ended March 29, 2025, principal repayments of $6.3 million and $2.5 million, respectively, were made on the Term Loan A Facility and Term Loan B Facility. There were no borrowings outstanding under the Revolver as of March 29, 2025 or December 31, 2024. We were in compliance with all the covenants under our debt agreements as of March 29, 2025.Other FinancingWe have overdraft facilities available that we use to support our cash management operations. We report any balances outstanding in the above table under "Other financing". There were no material borrowings outstanding under the overdraft facilities as of March 29, 2025 or December 31, 2024. We have financing leases that are reported in the above table under "Other financing" (refer to Note 7).

22

Perrigo Company plc - Item 1Note 12

NOTE 12 - EARNINGS PER SHARE AND SHAREHOLDERS' EQUITY

Earnings per ShareA reconciliation of the numerators and denominators used in our basic and diluted earnings per share ("EPS") calculation is as follows (in millions):  Three Months Ended March 29, 2025March 30, 2024Numerator:Income from continuing operations$0.1 $4.1 Loss from discontinued operations, net of tax(6.5)(2.1)Net income (loss) $(6.4)$2.0 Denominator:Weighted average shares outstanding for basic EPS137.7 136.6 Dilutive effect of share-based awards(1)— 1.0 Weighted average shares outstanding for diluted EPS137.7 137.6 (1) In the period of a net loss, diluted shares equal basic shares.Shareholders' Equity

In October 2018, our Board of Directors authorized up to $1.0 billion of share repurchases with no expiration date, subject to the Board of Directors’ approval of the pricing parameters and amount that may be repurchased under each specific share repurchase program (the "2018 Authorization"). We did not repurchase any shares during the three months ended March 29